HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Piramal Pharma reports consolidated net loss of Rs 136.19 crore in Q3
Jan-29-2026

Piramal Pharma has reported results for third quarter ended December 31, 2025 (Q3FY26).

The company has reported 8.51% rise in its net profit at Rs 128.91 crore for the third quarter ended December 31, 2025 as compared to Rs 118.80 crore for the same quarter in the previous year. Total income of the company increased by 1.49% at Rs 1,291.96 crore for Q3FY26 as compared to Rs 1,273.02 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net loss of Rs 136.19 crore for the third quarter ended December 31, 2025 as compared to net profit of Rs 3.68 crore for the same quarter in the previous year. Total income of the company decreased by 1.50% at Rs 2,183.11 crore for Q3FY26 as compared to Rs 2,216.35 crore for the corresponding quarter previous year.

  RELATED NEWS >>